Sort
11,323 grants matching “glioblastoma”
Identification of small molecule inhibitors of USP15
$259,560Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Microenvironment determinants of radio-sensitivity in human high grade glioma
$259,500Christopher Paul Cifarelli · West Virginia University · P20 · FY2018 · GM
Posttranslational regulation of augurin, a new secretory tumor suppressor
$259,500Akihiko Ozawa · Torrey Pines Inst For Molecular Studies · R21 · FY2013 · NS
Clinical Trial Operations Core
$259,215Annick Desjardins · Duke University · P50 · FY2019 · CA
Cytation 5 Cell Imaging Multi-Mode Reader
$259,158Paul Hergenrother · University Of Illinois At Urbana-Champaign · S10 · FY2019 · OD
Inhibition of glioma tumor growth by antisense MMP-9
$259,134University Of Illinois At Chicago · R01 · FY2003 · NS
Inhibition of glioma tumor growth by antisense MMP-9
$259,134University Of Illinois At Chicago · R01 · FY2004 · NS
Inhibition of glioma tumor growth by antisense MMP-9
$259,134University Of Illinois At Chicago · R01 · FY2005 · NS
Role and Therapeutic Value of AHR in Inflammatory Macrophages during GBM
$258,926Francisco J. Quintana · Brigham And Women'S Hospital · R21 · FY2014 · NS
Off-the-shelf Genetically Engineered Natural Killer Therapy for Glioblastoma
$258,822Katy Rezvani · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
The Mayo GBM Xenograft National Resource
$258,808Jann N Sarkaria · Mayo Clinic Rochester · R24 · FY2017 · NS
Targeting Translation Control in Malignant Glioma
$258,757Matthias Gromeier · Duke University · R01 · FY2011 · CA
Rheb GTPase as chemotherapeutic target for brain tumors
$258,690Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2005 · CA
Genetically engineered mouse models
$258,583Alain Charest · Massachusetts General Hospital · P01 · FY2012 · CA
Administration Core
$258,580Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2013 · CA
Development of novel synNotch CART cell therapy in adult patients with recurrent EGFRvIII+ glioblastoma
$258,407Hideho Okada · University Of California, San Francisco · U19 · FY2025 · CA
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
$258,308Brendan D. Manning · Harvard School Of Public Health · R01 · FY2012 · CA
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
$258,308Brendan D. Manning · Harvard School Of Public Health · R01 · FY2011 · CA
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase
$258,182Johannes Czernin · University Of California Los Angeles · P50 · FY2007 · CA
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase
$258,131Johannes Czernin · University Of California Los Angeles · P50 · FY2008 · CA
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene
$258,098Anna M Wu · University Of California Los Angeles · P50 · FY2007 · CA
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene
$258,048Anna M Wu · University Of California Los Angeles · P50 · FY2008 · CA
Boronated nucleosides for neutron capture therapy of brain tumors
$257,964Werner Tjarks · Ohio State University · R01 · FY2009 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$257,935David M. Ashley · Duke University · U19 · FY2024 · CA
RECONSTITUTION OF HEDGEHOG SIGNALING COMPLEX
$257,870University Of Cincinnati · R01 · FY2002 · CA